| (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
依折麦布杂质I |
1700622-07-6 |
| (3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
依折麦布杂质J |
1700622-08-7 |
| Ezetimibe Impurity 38 |
Ezetimibe Impurity 38 |
1701462-59-0 |
| N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
托法替尼杂质 N |
1702274-61-0 |
| 1-(4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)ethanone |
奥美沙坦杂质3 |
1227626-50-7 |
| Trityl olMesartan MedoxoMil iMpurity III |
奥美沙坦酯杂质F |
1227626-51-8 |
| 2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate |
替格瑞洛杂质F |
1616703-93-5 |
| Prasugrel Impurity 13 HCl |
普拉格雷杂质13 |
1618108-01-2 |
| Alogliptin Related Compound 23 |
阿格列汀杂质07 |
1618644-29-3 |
| Alogliptin benzoate impurity K |
Alogliptin benzoate impurity K |
1618644-32-8 |
| 4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1) |
厄洛替尼杂质 |
1624294-38-7 |
| Canagliflozin α Isomer |
卡格列净异构体 |
1589590-87-3 |
| Rupatadine IMpurity C |
氯雷他定羟基哌N -氧化物 |
1224515-72-3 |
| Ibrutinib D5 |
伊布替尼布D5 |
1553977-17-5 |
| 2-(3-cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦杂质U |
1530308-87-2 |
| Solifenacin EP Impurity B |
索利那新杂质 B |
1534326-81-2 |
| AcarBose EP Impurity B |
阿卡波糖EP杂质B |
1220983-54-9 |
| Ticagrelor Related Compound 44 |
替格瑞洛杂质44 |
1431867-40-1 |
| lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate |
锂 2-(4-(甲基磺酰基)苯基)乙酸酯 |
1421227-96-4 |
| Etoricoxib Impurity 8 |
依托考昔杂质 8 |
1421227-97-5 |
QQ
微信
